Bioengineering Laboratories was awarded the second prize at the Business Plan Competition of the 5th World Congress of TERMIS – Tissue Engineering and Regenerative Medicine International Society (Kyoto, Japan, https://www.termis.org/wc2018). BEL’s business plan and presentation pitch focused on the DIALYBRID project, aimed at revolutionizing the world of hemodialysis with a novel, hybrid vascular access made of Silkothane®.
